Related references
Note: Only part of the references are listed.Safety of N-Acetylcysteine at High Doses in Chronic Respiratory Diseases: A Review
Peter Calverley et al.
DRUG SAFETY (2021)
Predictors of Single Bronchodilation Treatment Response for COPD: An Observational Study with the Trace Database Cohort
Laura Carrasco Hernandez et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Considerations for and Mechanisms of Adjunct Therapy in COPD
Rachana Mandru et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Increased von Willebrand Factor Processing in COPD, Reflecting Lung Epithelium Damage, Is Associated with Emphysema, Exacerbations and Elevated Mortality Risk
Lasse L. Langholm et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2020)
Cryptotanshinone reverses the epithelial-mesenchymal transformation process and attenuates bleomycin-induced pulmonary fibrosis
Qianyu Zhang et al.
PHYTOTHERAPY RESEARCH (2020)
Oxidative stress-based therapeutics in COPD
Peter J. Barnes
REDOX BIOLOGY (2020)
Protective effect of Alpinetin on rats with chronic obstructive pulmonary disease
Yu Su et al.
FOOD SCIENCE & NUTRITION (2020)
Protective effect of amygdalin on epithelial-mesenchymal transformation in experimental chronic obstructive pulmonary disease mice
Ziyan Wang et al.
PHYTOTHERAPY RESEARCH (2019)
CD147 increases mucus secretion induced by cigarette smoke in COPD
Qiao Yu et al.
BMC PULMONARY MEDICINE (2019)
N-acetylcysteine Decreases Fibrosis and Increases Force-Generating Capacity of mdx Diaphragm
David P. Burns et al.
ANTIOXIDANTS (2019)
N-Acetylcysteine potentiates the haemodynamic-improving effect of sildenafil in a rabbit model of acute pulmonary thromboembolism via the p38 MAPK pathway
Ruipeng Zhang et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2019)
Overexpression of Forkhead box C1 attenuates oxidative stress, inflammation and apoptosis in chronic obstructive pulmonary disease
Shuyue Xia et al.
LIFE SCIENCES (2019)
The effect of N-acetylcysteine on exacerbations of chronic obstructive pulmonary disease: A meta-analysis and systematic review
Kaushal Fowdar et al.
HEART & LUNG (2017)
Immunomodulatory effects of two different physical therapy modalities in patients with chronic obstructive pulmonary disease
Sherin Hassan M. Mehani
Journal of Physical Therapy Science (2017)
The Expression of IL-6, TNF-alpha, and MCP-1 in Respiratory Viral Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Jingtong Zheng et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2017)
Effect of Liuweibuqi Capsules in Pulmonary Alveolar Epithelial Cells and COPD Through JAK/STAT Pathway
Chengyang Wang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Epithelial and endothelial cell plasticity in chronic obstructive pulmonary disease (COPD)
Sukhwinder Singh Sohal
RESPIRATORY INVESTIGATION (2017)
Nephroprotective Effects of N-Acetylcysteine Amide against Contrast-Induced Nephropathy through Upregulating Thioredoxin-1, Inhibiting ASK1/p38MAPK Pathway, and Suppressing Oxidative Stress and Apoptosis in Rats
Xuezhong Gong et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Probing Cellular and Molecular Mechanisms of Cigarette Smoke-Induced Immune Response in the Progression of Chronic Obstructive Pulmonary Disease Using Multiscale Network Modeling
Zhichao Pan et al.
PLOS ONE (2016)
Increased expression of TROP2 in airway basal cells potentially contributes to airway remodeling in chronic obstructive pulmonary disease
Qixiao Liu et al.
RESPIRATORY RESEARCH (2016)
COPD and its comorbidities: Impact, measurement and mechanisms
Netsanet A. Negewo et al.
RESPIROLOGY (2015)
Gene expression changes caused by the p38 MAPK inhibitor dilmapimod in COPD patients: analysis of blood and sputum samples from a randomized, placebo-controlled clinical trial
Joanna C. Betts et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2015)
Benefits of High-Dose N-Acetylcysteine to Exacerbation-Prone Patients With COPD
Hoi Nam Tse et al.
CHEST (2014)
N-Acetylcysteine for thrombotic thrombocytopenic purpura: is a von Willebrand factor-inhibitory dose feasible in vivo?
Jake Shortt et al.
TRANSFUSION (2014)
Efficacy and safety of the p38 MAPK inhibitor losmapimod for patients with chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial
Henrik Watz et al.
LANCET RESPIRATORY MEDICINE (2014)
Increased phosphorylated p38 mitogen-activated protein kinase in COPD Lungs
Kate Gaffey et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Effect of acute exacerbations on circulating endothelial, clotting and fibrinolytic markers in COPD patients
Riccardo Polosa et al.
INTERNAL AND EMERGENCY MEDICINE (2013)
The secretion of von Willebrand factor from endothelial cells; an increasingly complicated story
T. Nightingale et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Effects of N-Acetylcysteine in Ozone-Induced Chronic Obstructive Pulmonary Disease Model
Feng Li et al.
PLOS ONE (2013)
Cigarette smoke extract stimulates epithelial-mesenchymal transition through Src activation
Hongqiao Zhang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Effects of p38 Mitogen-Activated Protein Kinase Inhibition on Vascular and Systemic Inflammation in Patients With Atherosclerosis
Maysoon Elkhawad et al.
JACC-CARDIOVASCULAR IMAGING (2012)
N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice
Junmei Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Synergistic Effects of p38 Mitogen-Activated Protein Kinase Inhibition with a Corticosteroid in Alveolar Macrophages from Patients with Chronic Obstructive Pulmonary Disease
J. Armstrong et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Oral N-acetylcysteine attenuates pulmonary emphysema and alveolar septal cell apoptosis in smoking-induced COPD in rats
Shan Cai et al.
RESPIROLOGY (2009)
Oral N-acetylcysteine attenuates elastase-induced pulmonary emphysema in rats
ML Rubio et al.
CHEST (2004)
Share Paper
